Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$9.74 +0.09 (+0.93%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Capital Expenditures (2011 - 2026)

Updated

Tonix Pharmaceuticals Holding (TNXP) reported Capital Expenditures of $587,000 for Q2 2026, up 11.4% from $527,000 a year earlier but down 65.3% from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Capital Expenditures (2011 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Tonix Pharmaceuticals Holding's Capital Expenditures came in at $5.12 million, up 838.5% year-over-year; for FY2025, it was $3.37 million.

  • Capital Expenditures has a five-year compound annual growth rate of -17.0% (FY2020 to FY2025).
  • By year, Capital Expenditures came in at $120,000 in FY2024 (-98.5%), $7.9 million in FY2023 (-83.6%), $48.15 million in FY2022 (+36.4%) and $35.31 million in FY2021 (+312.3%).
  • Five-year quarterly Capital Expenditures spans a low of $3,000 in Q4 2024 and a high of $25.62 million in Q4 2021.
  • Year over year, Capital Expenditures gained in 1 of the last four quarters, with an average decline of 70.5%.
  • The high point for year-over-year Capital Expenditures in five years was Q2 2022 (growth of 910.4%); the low point was Q3 2024 (a decline of 99.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.69 million (Q1 2026), $1.87 million (Q4 2025) and $962,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Tonix Pharmaceuticals Holding 163.56 Mn 163.56 Mn 12.84 Mn 587,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 587,000.00
Mar 31, 2026 1.69 Mn
Dec 31, 2025 1.87 Mn
Sep 30, 2025 962,000.00
Jun 30, 2025 527,000.00
Mar 31, 2025 6,000.00
Dec 31, 2024 3,000.00
Sep 30, 2024 9,000.00
Mar 31, 2024 108,000.00
Dec 31, 2023 438,000.00
Sep 30, 2023 1.81 Mn
Jun 30, 2023 1.85 Mn
Mar 31, 2023 3.80 Mn
Dec 31, 2022 4.67 Mn
Sep 30, 2022 8.82 Mn
Jun 30, 2022 14.44 Mn
Mar 31, 2022 20.22 Mn
Dec 31, 2021 25.62 Mn
Sep 30, 2021 7.75 Mn
Jun 30, 2021 1.43 Mn
API Access

Tonix Pharmaceuticals Holding Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TNXP&period=max&api_key=YOUR_API_KEY